269 related articles for article (PubMed ID: 9230887)
1. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.
Cavallo F; Signorelli P; Giovarelli M; Musiani P; Modesti A; Brunda MJ; Colombo MP; Forni G
J Natl Cancer Inst; 1997 Jul; 89(14):1049-58. PubMed ID: 9230887
[TBL] [Abstract][Full Text] [Related]
2. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
[TBL] [Abstract][Full Text] [Related]
3. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.
Giovarelli M; Musiani P; Modesti A; Dellabona P; Casorati G; Allione A; Consalvo M; Cavallo F; di Pierro F; De Giovanni C
J Immunol; 1995 Sep; 155(6):3112-23. PubMed ID: 7673726
[TBL] [Abstract][Full Text] [Related]
4. Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity.
Puisieux I; Odin L; Poujol D; Moingeon P; Tartaglia J; Cox W; Favrot M
Hum Gene Ther; 1998 Nov; 9(17):2481-92. PubMed ID: 9853515
[TBL] [Abstract][Full Text] [Related]
5. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
Allione A; Consalvo M; Nanni P; Lollini PL; Cavallo F; Giovarelli M; Forni M; Gulino A; Colombo MP; Dellabona P
Cancer Res; 1994 Dec; 54(23):6022-6. PubMed ID: 7954438
[TBL] [Abstract][Full Text] [Related]
6. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.
Di Carlo E; Coletti A; Modesti A; Giovarelli M; Forni G; Musiani P
Eur Cytokine Netw; 1998 Mar; 9(1):61-8. PubMed ID: 9613679
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
8. Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.
Giovarelli M; Cappello P; Forni G; Salcedo T; Moore PA; LeFleur DW; Nardelli B; Di Carlo E; Lollini PL; Ruben S; Ullrich S; Garotta G; Musiani P
J Immunol; 2000 Mar; 164(6):3200-6. PubMed ID: 10706711
[TBL] [Abstract][Full Text] [Related]
9. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice.
Provinciali M; Argentati K; Tibaldi A
Gene Ther; 2000 Apr; 7(7):624-32. PubMed ID: 10819579
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
Zou JP; Yamamoto N; Fujii T; Takenaka H; Kobayashi M; Herrmann SH; Wolf SF; Fujiwara H; Hamaoka T
Int Immunol; 1995 Jul; 7(7):1135-45. PubMed ID: 8527411
[TBL] [Abstract][Full Text] [Related]
12. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12.
Cavallo F; Di Carlo E; Butera M; Verrua R; Colombo MP; Musiani P; Forni G
Cancer Res; 1999 Jan; 59(2):414-21. PubMed ID: 9927056
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines.
Rodolfo M; Zilocchi C; Melani C; Cappetti B; Arioli I; Parmiani G; Colombo MP
J Immunol; 1996 Dec; 157(12):5536-42. PubMed ID: 8955204
[TBL] [Abstract][Full Text] [Related]
14. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells.
Vagliani M; Rodolfo M; Cavallo F; Parenza M; Melani C; Parmiani G; Forni G; Colombo MP
Cancer Res; 1996 Feb; 56(3):467-70. PubMed ID: 8564954
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory.
Consalvo M; Mullen CA; Modesti A; Musiani P; Allione A; Cavallo F; Giovarelli M; Forni G
J Immunol; 1995 May; 154(10):5302-12. PubMed ID: 7730633
[TBL] [Abstract][Full Text] [Related]
17. Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.
Nanni P; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Rossi I; Cavallo F; Giovarelli M; Forni G; Lollini PL
Br J Cancer; 1996 Nov; 74(10):1564-9. PubMed ID: 8932336
[TBL] [Abstract][Full Text] [Related]
18. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
Stoppacciaro A; Forni G; Colombo MP
Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect to IL-12 administration into the portal vein on murine liver metastasis.
Su W; Kitagawa T; Ito T; Oyama T; Lee CM; Kim YK; Matsuda H
J Hepatobiliary Pancreat Surg; 2002; 9(4):503-10. PubMed ID: 12483274
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma.
Modesti A; Masuelli L; Modica A; D'Orazi G; Scarpa S; Bosco MC; Forni G
Int J Cancer; 1993 Apr; 53(6):988-93. PubMed ID: 8473057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
